contact  |  disclaimer  |  intranet

 

  Home

 

  

  SARS

 

   • Introduction

 • Outbreak

 • 2003 SARS epidemic

 • Virus hunting

 • Coronaviruses

 • Virus evolution

 • Control

 • Novel coronaviruses

 • Future research

 

 

     

SARS-DTV consortium

  (Documents from the year  2004

  when SARS-DTV research started)

 • SARS-DTV research plan

 • SARS-DTV: who we are

 • SARS-DTV leaflet

 • Contact information

  

  SARS-DTV publications

  (2004-2008)

 

  SARS-DTV final report

  (2008)

 

 

 

  Useful links

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Last update: October 2005

 

  

 

 

 

 

 

 

 

Partner 12 - Inserm Transfert

Project Management

 

Inserm Transfert, a subsidiary of the French Institute for Health and Medical Research, is the public limited company that is responsible for the project management and possesses extensive expertise in two core areas. Technology transfer, and the funding and creation of biotechnology enterprises represent one of its core expertises. The second core expertise is dedicated to project management activities, including the management of FP6 European projects (22 currently) clinical trials. Inserm Transfert invest significant effort to educate researchers in the field and heighten their awareness of the opportunities, with a view of ensuring optimal use of the generated knowledge.

Dr. Jerome Weinbach is the SARS-DTV project manager at Inserm Transfert. Since March 2001, he has already prepared and managed two EU-funded projects from Prof. Spaan's laboratory (Partner 1) at LUMC, which brought together 20 laboratories from eight different countries of the European Union. These clusters aim at the successful development of preventive and therapeutic vaccines against hepatitis C virus (HCV). An evaluation by external experts (EU mid-term review) in March 2002 has underlined the quality of his work. Dr. Weinbach has also coordinated the preparation of a successful FP6 proposal, a Network of Excellence called viRgil focussing on antiviral drug resistance, which will have obvious and strategic interactions with the SARS-DTV network with regards to SARS-CoV-resistance aspects.
To fulfil his mission, Dr. Weinbach will take advantage of his membership in the European Association of Research Managers and Administrators (EARMA), his former complementary experiences both in research (Ph.D. in gene therapy / lecturer in cancer research) and as the Scientific Attaché for life sciences and biotechnology at the French Embassy in Germany (1996-1998), then in the United Kingdom (London, 1998-2000). He is familiar with a variety of the field's concepts, practices, and procedures, and his decisions rely on extensive experience and judgment to plan and accomplish goals.

Ibahima Guillard is Junior Project Manager at Inserm-Transfert since April 2004. After a ground education in Life Sciences and biological industries, he broadened his skills getting a Master Degree in Biotechnologies and a Master Degree in Business Management in 2002. His interests are to use his skills in order to help bridging the gap existing between the scientific research culture and the Industry culture, helping the two sides perform together.
Working with Dr Weinbach since April 2004 he has been working at the management of several various sized international projects (Network of Excellence, Specifically Targeted REsearch Project) in the infectious diseases field in general and the viral pathologies in particular.

Dr J. Weinbach
Jerome.weinbach@inserm-transfert.fr

Ibrahima Alexis Guillard
Ibrahima-alexis.guillard@inserm-transfert.fr